3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
33
Lymphoma
17
Lymphoma, Large-Cell, Anaplastic
15
Hematologic Diseases
13
Lymphoma, Non-Hodgkin
10
Recurrence
9
Lymphoma, T-Cell
7
Lymphoma, T-Cell, Peripheral
6
Lymphoma, Large B-Cell, Diffuse
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
4
Neoplasms
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Cutaneous
3
Lymphatic Diseases
3
Leukemia
3
Immunoblastic Lymphadenopathy
3
Sezary Syndrome
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasms by Histologic Type
2
Lymphoproliferative Disorders
2
Lymphoma, Extranodal NK-T-Cell
2
Leukemia, Myeloid, Acute
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Enteropathy-Associated T-Cell Lymphoma
2
Waldenstrom Macroglobulinemia
1
Testicular Neoplasms
1
Nonseminomatous germ cell tumor
1
Interventions
Cyclophosphamide
34
fludarabine
25
fludarabine phosphate
24
Tacrolimus
24
Mycophenolic Acid
23
Whole-Body Irradiation
22
Busulfan
15
Methotrexate
12
Melphalan
12
Granulocyte Colony-Stimulating Factor
12
Antilymphocyte Serum
12
thymoglobulin
11
Cyclosporine
11
Stem Cell Transplantation
10
Filgrastim
10
Rituximab
9
Thiotepa
7
Peripheral Blood Stem Cell Transplantation
7
Nivolumab
7
Dexamethasone
7
trametinib
6
Radiotherapy
6
Mesna
6
Cytarabine
6
Prednisone
5
Calcium Dobesilate
5
Bortezomib
5
Azacitidine
5
Alemtuzumab
5
Voriconazole
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Neoplasms
×
Brentuximab Vedotin
×
Clear all
No trials found.